Leerink Swann Analysts Decrease Earnings Estimates for Amgen, Inc.


Research analysts at Leerink Swann decreased their Q4 2017 earnings estimates for shares of Amgen in a research note issued on Thursday. Leerink Swann analyst G. Porges now forecasts that the medical research company will post earnings per share of $2.90 for the quarter, down from their prior forecast of $2.93.



from Biotech News